Needham analyst Mike Matson maintains Conmed (NYSE:CNMD) with a Buy and raises the price target from $90 to $106.
Mizuho Maintains Buy Rating for RingCentral: Here’s What You Need To Know
Mizuho has decided to maintain its Buy rating of RingCentral (NYSE:RNG) and lower its price target from $150.00 to $80.00.
Shares of RingCentral are trading up 6.76% over the last 24 hours, at $53.06 per share.
A move to $80.00 would account for a 50.77% increase from the current share price.
